These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients. Corrada E, Cappelleri A, Belli G, Genovese S, Barbaro C, Gasparini G, Pagnotta P, Rossi M, Zavalloni D, Presbitero P. Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179 [Abstract] [Full Text] [Related]
25. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM, National Institutes of Health-National Heart, Lung, and Blood Institute. Circulation; 2004 Jun 22; 109(24):2993-9. PubMed ID: 15197152 [Abstract] [Full Text] [Related]
28. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis. Romano G, Corrado E, Muratori I, Novo G, Andolina G, Cospite V, Evola S, Ciaramitaro GF, Di Vincenzo A, Farinella M, Rotolo A, Assennato P, Hoffmann E, Novo S. Int Angiol; 2006 Dec 22; 25(4):389-94. PubMed ID: 17164746 [Abstract] [Full Text] [Related]
29. No gender difference in the clinical management and outcome of unstable angina. Ben-Ami T, Gilutz H, Porath A, Sosna G, Liel-Cohen N. Isr Med Assoc J; 2005 Apr 22; 7(4):228-32. PubMed ID: 15847201 [Abstract] [Full Text] [Related]
30. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC. Am J Cardiol; 2009 Nov 01; 104(9):1210-5. PubMed ID: 19840564 [Abstract] [Full Text] [Related]
32. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Bonello L, De Labriolle A, Lemesle G, Steinberg DH, Roy P, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):866-70. PubMed ID: 19198009 [Abstract] [Full Text] [Related]
33. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group. Catheter Cardiovasc Interv; 2009 May 01; 73(6):763-8. PubMed ID: 19309731 [Abstract] [Full Text] [Related]
35. [Peripheral vascular disease: prevalence, mortality and relationship with inflammation in hemodialysis]. Vega A, Pérez García R, Abad S, Verde E, López Gómez JM, Jofré R, Puerta M, Rodríguez P. Nefrologia; 2008 May 01; 28(3):311-6. PubMed ID: 18590498 [Abstract] [Full Text] [Related]
36. Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years. Zhang Q, Xu B, Yang YJ, Qiao SB, Zhang RY, Zhang JS, Hu J, Qin XW, Chen JL, Shen WF, Gao RL. Chin Med J (Engl); 2008 Sep 05; 121(17):1670-4. PubMed ID: 19024097 [Abstract] [Full Text] [Related]